Skip to Content

G 0522 G 0522 (Fenofibrate (micronized) 134 mg)

Pill imprint G 0522 G 0522 has been identified as Fenofibrate (micronized) 134 mg.

Fenofibrate is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia; hyperlipoproteinemia type iv, elevated vldl; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia type iib, elevated ldl vldl (and more), and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 134 mg is not a controlled substance under the Controlled Substance Act (CSA).

Fenofibrate (micronized) 134 mg G 0522 G 0522
Fenofibrate (micronized) 134 mg G 0522 G 0522
Fenofibrate (micronized) 134 mg G 0522 G 0522 Front
Fenofibrate (micronized) 134 mg G 0522 G 0522 Back
Fenofibrate (micronized) 134 mg G 0522 G 0522
Fenofibrate (micronized)
G 0522 G 0522
134 mg
19.00 mm
Prescription only
Drug Class:
Fibric acid derivatives
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Global Pharmaceuticals
National Drug Code (NDC):
Inactive Ingredients:
croscarmellose sodium
magnesium stearate
microcrystalline cellulose
sodium lauryl sulfate
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
68084-0835 Amerisource Health Services
54868-5994 Physicians Total Care Inc (repackager)

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.